Abstract
Multidrug-resistant tuberculosis is a major issue worldwide; however, accessibility to drug susceptibility testing (DST) is still limited in developing countries, owing to high costs and complexity. We developed a proportion method on 12-well microplates for DST. The assay reduced the time to results to <12 days and <10 days when bacterial growth was checked with the naked eye or a microscope, respectively. Comparison with the Canetti-Grosset method showed that the results of the two assays almost overlapped (kappa index 0.98 (95% CI 0.91-1.00) for isoniazid, rifampicin, streptomycin; and kappa index 0.92 (95% CI 0.85-0.99) for ethambutol). The sequencing of genes involved in drug resistance showed similar level of phenotype-genotype agreement between techniques. Finally, measurement of the MICs of rifampicin and ethambutol suggests that the currently used critical ethambutol concentration should be revised, and that the current molecular drug susceptibility tests for rifampicin need to be re-evaluated, as in vitro rifampicin-sensitive isolates could harbour drug resistance-associated mutation(s).
References
Oct 1, 1995·Antimicrobial Agents and Chemotherapy·G S PretoriusT C Victor
Nov 29, 2001·Journal of Clinical Microbiology·F ArditoG Fadda
Aug 30, 2005·Antimicrobial Agents and Chemotherapy·Manzour Hernando HazbónDavid Alland
Jan 5, 2006·Journal of Clinical Microbiology·Claudio PiersimoniClaudio Scarparo
Jul 28, 2006·Antimicrobial Agents and Chemotherapy·Emma HuitricSven Hoffner
Nov 10, 2006·Journal of Clinical Microbiology·Leen RigoutsFrançoise Portaels
Nov 17, 2006·Journal of Clinical Microbiology·Jun-ichiro SekiguchiTeruo Kirikae
Apr 4, 2007·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·M Y LipinT M Shinnick
Jun 1, 2007·Journal of Clinical Microbiology·Bert van KlingerenDick van Soolingen
Jan 17, 2009·BMC Microbiology·Anna ZaczekJaroslaw Dziadek
Sep 15, 2009·Journal of Infection in Developing Countries·Agatha E AniJ Idoko
Sep 18, 2009·Journal of Clinical Microbiology·A Van DeunA Wright
Sep 4, 2010·The Lancet Infectious Diseases·Jessica MinionMadhukar Pai
Jan 7, 2011·Journal of Clinical Microbiology·Ruth Ann LunaJames Versalovic
Feb 9, 2011·Antimicrobial Agents and Chemotherapy·Patricia J CampbellJames E Posey
Aug 11, 2011·The European Respiratory Journal·D FalzonM Zignol
Mar 1, 2012·PloS One·Ann S G LeeWing-Cheong Yam
Mar 2, 2012·BMC Infectious Diseases·Thi Minh Ha DangMaxine Caws
Sep 18, 2012·Bulletin of the World Health Organization·Kristian ÄngebyThomas Schön
Oct 23, 2013·Antimicrobial Agents and Chemotherapy·Sönke AndresElvira Richter
Mar 7, 2014·PloS One·Oksana OcheretinaDaniel W Fitzgerald
Aug 12, 2014·BMC Research Notes·Wassihun WedajoAbraham Aseffa
Mar 1, 2013·Global Health, Science and Practice·Amy S PiatekYaDiul Mukadi
Citations
Oct 12, 2017·Emerging Microbes & Infections·Nguyen Quang HuyNguyen Thi Van Anh
May 7, 2019·Frontiers in Microbiology·Thi Ngoc Anh NguyenThi Van Anh Nguyen
Nov 30, 2020·Comparative Immunology, Microbiology and Infectious Diseases·Jessy Lallungawi KhawbungSupriyo Chakraborty
Apr 17, 2021·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Jiahui ZhuSven Hoffner